FDA approves Johnson & Johnson's ketamine-like nasal spray for depression

InThe U.S. Food and Drug Administration
Johnson & Johnson's
FDA
Spravato
K.The
Center for Drug Evaluation and Research
J&J
CNBC
CNBC LLC
All Rights Reserved
Division
NBCUniversalData
Global Business and Financial News
Market Data and Analysis

Tiffany Farchione
Janssen

No matching tags

Positivity 30.00%

Negativity 70.00%

SOURCE: https://www.cnbc.com/2019/03/06/us-fda-approves-jjs-ketamine-like-nasal-spray-for-depression.html

Write a review: CNBC

Summary

The U.S. Food and Drug Administration on Tuesday said it approved Johnson & Johnson's nasal spray antidepressant that is chemically similar to often-abused ketamine, marking the first advance in treating depression in more than 30 years.

As said here by Reuters

FDA approves Johnson & Johnson's ketamine-like nasal spray for depression

Companies, agencies, institutions, etc

People

Groups

Physical locations

Places

Locations

Events

Summary

Reuters